Treatment of chronic urinary salmonella carriers with trimethoprim-sulphamethoxazole.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001769:Blood / Q000382:microbiology; D002353:Carrier State / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D012480:Salmonella Infections / Q000188:drug therapy*; D012482:Salmonella paratyphi A / Q000302:isolation & purification; D012485:Salmonella typhi / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole